pdufa.bio

TECVAYLI (teclistamab-cqyv)

Updated ยทnext FDA decision on the calendar

TECVAYLI (teclistamab-cqyv) 2 FDA decisions on record below. Every date links its source.

HALO catalyst hub · JNJ catalyst hub

About this program

We track 2 catalyst events for this program: 0 upcoming and 2 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Mar 5, 2026 ✓ ApprovedHALOPDUFA · Mar 5, 2026 ✓ ApprovedJNJ

Questions

When is TECVAYLI (teclistamab-cqyv)'s next FDA decision or readout?

No upcoming catalyst is on our calendar for TECVAYLI (teclistamab-cqyv); 2 FDA decisions are on record below.

What happened at TECVAYLI (teclistamab-cqyv)'s most recent FDA decision?

On Mar 5, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.